Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Prandi

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Genome Biology|August 28, 2014
Unraveling the clonal hierarchy of somatic genomic aberrationsDavide Prandi, Sylvan C Baca, Alessandro Romanel, et al.
The Journal of Clinical Investigation|December 24, 2024
CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancerGiulia Fracassi, Francesca Lorenzin, Francesco Orlando, et al.
JCO Precision Oncology|October 5, 2020
Systematic Assessment of Tumor Purity and Its Clinical ImplicationsSyed Haider, Svitlana Tyekucheva, Davide Prandi, et al.
Nature Genetics|November 8, 2016
Clonal evolution of chemotherapy-resistant urothelial carcinomaBishoy M Faltas, Davide Prandi, Scott T Tagawa, et al.
The Journal of Clinical Investigation|May 17, 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancerDeli Liu, Michael A Augello, Ivana Grbesa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2019
Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissuesErez Persi, Davide Prandi, Yuri I Wolf, et al.
Science Translational Medicine|September 19, 2014
Tumor clone dynamics in lethal prostate cancerSuzanne Carreira, Alessandro Romanel, Jane Goodall, et al.
The Journal of Pathology|February 27, 2022
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studiesJoanna Cyrta, Davide Prandi, Arshi Arora, et al.
Elife|September 17, 2015
SPOP mutation leads to genomic instability in prostate cancerGunther Boysen, Christopher E Barbieri, Davide Prandi, et al.
Nature Medicine|February 9, 2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerHimisha Beltran, Davide Prandi, Juan Miguel Mosquera, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Genome Biology|August 28, 2014
Unraveling the clonal hierarchy of somatic genomic aberrationsDavide Prandi, Sylvan C Baca, Alessandro Romanel, et al.
The Journal of Clinical Investigation|December 24, 2024
CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancerGiulia Fracassi, Francesca Lorenzin, Francesco Orlando, et al.
JCO Precision Oncology|October 5, 2020
Systematic Assessment of Tumor Purity and Its Clinical ImplicationsSyed Haider, Svitlana Tyekucheva, Davide Prandi, et al.
Nature Genetics|November 8, 2016
Clonal evolution of chemotherapy-resistant urothelial carcinomaBishoy M Faltas, Davide Prandi, Scott T Tagawa, et al.
The Journal of Clinical Investigation|May 17, 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancerDeli Liu, Michael A Augello, Ivana Grbesa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2019
Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissuesErez Persi, Davide Prandi, Yuri I Wolf, et al.
Science Translational Medicine|September 19, 2014
Tumor clone dynamics in lethal prostate cancerSuzanne Carreira, Alessandro Romanel, Jane Goodall, et al.
The Journal of Pathology|February 27, 2022
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studiesJoanna Cyrta, Davide Prandi, Arshi Arora, et al.
Elife|September 17, 2015
SPOP mutation leads to genomic instability in prostate cancerGunther Boysen, Christopher E Barbieri, Davide Prandi, et al.
Nature Medicine|February 9, 2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerHimisha Beltran, Davide Prandi, Juan Miguel Mosquera, et al.
Pageof 3